www.fdanews.com/articles/175920-apotex-launches-first-generic-version-of-mercks-nasonex-spray
Apotex Launches First Generic Version of Merck’s Nasonex Spray
March 28, 2016
Apotex has launched the first generic version of Merck’s once-daily Nasonex spray, the drugmaker announced last week.
Nasonex raked in roughly $955.5 million in sales in a 12-month period that ended in January, according to IMS Health.
In June 2013, the Federal Circuit upheld a decision that Apotex had not infringed patents covering the drug.